Join us at eCheminfo Euro

eChemInfo workshop

Final Announcement for the eChemInfo Training and Innovation Course in Drug Design 2017 in Milano

This is a final eminder that the Training and Innovation Course in Drug Design will take place at the Department of Pharmaceutical Sciences, University of Milano from Mon, 17 Jul. to Fri, 21 Jul. 2017.

The final program is available at http://www.echeminfo.com/events/drug-design-euro-2017

We will have three exiting key notes:

  • Malaria Drug Discovery Methods, Donatella Taramelli, University of Milan
  • Aspects of Industrial Drug Design, Anna Maria Capelli, Chiesi
  • Design of Cyclopeptidic Drugs, Laura Belvisi / Monica Civera, University of Milan

We are also very happy to be able this year to strongly integrate experimental techniques into the workshop. Stefan Jehle from Bruker BioSpin AG, the leading company in biomolecular NMR spectroscopy, will give a session on “NMR-driven Fragment Based Drug Design”. And we have Anthony Bradley from the Diamond Light Source's XChem project, which provides services for complex structure determination using medium- to high-throughput X-ray. He will give a presentation together with Tim Dudgeon (Informatics Matters) on “Moving from Individual Tools to Complete Workflows”.

And just to remind you on our special setup of the workshop: Use the “bring your own problems” option to directly apply your newly acquired knowledge to your own research, profit from specific advice by the experts and other participants and contribute to innovative approaches for all case studies. You can also present a poster of your work to give the other attendees an overview of your work and foster discussions within the groups.

We would highly appreciate if you could showcase the workshop poster (http://www.echeminfo.com/Milano2017_Poster.pdf) on your notice boards.

Register now at https://goo.gl/au4QBW

 

Dr Thomas Exner is a Chief Scientific Officer (CSO) at Douglas Connect

 

Add new comment

Refresh Type the characters you see in this picture. Type the characters you see in the picture; if you can't read them, submit the form and a new image will be generated. Not case sensitive.  Switch to audio verification.

About Douglas Connect

Douglas Connect manages collaborative projects to achieve goals in scientific research, infrastructure development or service provision. Effective collaboration requires many elements including coordination, culture, communications, common understanding, decision-making and interoperability.

Tags

Latest Tweets

Douglas Connect (6 days ago)
RT @EU_ToxRisk: Nice paper in "Regulatory Toxicology and Pharmacology" about #PBK models and how they support #regulatory #riskassessment.…
Douglas Connect (2 weeks ago)
RT @barryhardy: Impact of New Methods in #Food and #Drug #Safety #Assessment - Summary from the Global Summit on #Regulatory #Science https…
Douglas Connect (3 weeks ago)
Decision-making about safety assessment is undergoing a major transition. https://t.co/EX5kf9eDZK #OpenTox #safetyassessment
Douglas Connect (4 weeks ago)
OpenTox Euro 2017 is now less than a month away, please reserve your place now! https://t.co/ophtCvO3dX … #OpenTox… https://t.co/lbjpMxV0Vf
Douglas Connect (4 weeks ago)
The October OpenTox Newsletter is now available: https://t.co/fb6MoaKdO3 #OpenTox #safety #science #toxicology

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com